Form 4 for APYX Apyx Medical Corp
Accepted 2023-03-22 00:00:00 ET · period of report 2022-01-07 · accession 0000719135-23-000020 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-22 | 2022-01-07 | APYX | Swandal Craig A. | Dir | M - OptEx | $9.42 | +7,173 | 60.2K | +14% | +$67.6K |
| D | 2023-03-22 | 2022-01-07 | APYX | Swandal Craig A. | Dir | M - OptEx | $0.00 | -7,173 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-07 | M | A | 7,173 | $9.42 | 60,173 | D | — | — | |
| 2 | Derivative | Stock Option (Option to Buy) | 2022-01-07 | M | D | 7,173 | $0.00 | 0 | D | $9.42 · 2022-08-06 to 2031-08-06 | 7,173 Common Stock |